REUTERS/Piroschka van de WouwRegister now for FREE endless access to Reuters.comRegisterAMSTERDAM, Feb 15 (Reuters) – Dutch specialized chemicals maker DSM (DSMN.AS) posted a 13% dive in fourth-quarter core earnings on Tuesday, beating experts price quotes, buoyed by robust need for its dietary products despite higher prices.DSM, which provides products varying from vitamins and other food supplements to customized plastics used in vehicles, clothing and building, stated it had raised its costs in the second half of last year to offset increasing raw material costs.”The very first favorable effects can be seen in the 4th quarter, with the remainder being efficient as of 2022″, co-Chief Executive Officers Geraldine Matchett and Dimitri de Vreeze said.Register now for FREE unrestricted access to Reuters.comRegisterThe businesss adjusted profits before interest, taxes, devaluation and amortisation (EBITDA) for the quarter ended Dec. 31 rose to 440 million euros ($497.95 million), up from 390 million a year prior to.
